| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | TELADOC TECHNOLOGIES INC CMN | Jan 6, 2026 | |
| Buy | TELADOC DESK INC | Dec 12, 2025 | |
| Sell | Trade Desk Inc | Sep 19, 2025 | |
| Sell | TELADOC INC CMN | Feb 19, 2025 | |
| Buy | TELADOC HEALTH INC CMN | Feb 5, 2025 | |
| Buy | TELADOC HEALTH INC CMN | Jan 29, 2025 | |
| Sell | TELEDYNE TECHNOLOGIES INCORP | Jan 17, 2025 | |
| Buy | TELADOC HEALTH INC CMN | Jan 12, 2025 | |
| Buy | TELEDYNE TECHNOLOGIES INCORP | Jun 29, 2023 | |
| Buy | TELADOC HEALTH INC CMN | Jun 26, 2023 |
This page tracks congressional stock trading activity in Teladoc Health, Inc. (TDOC) in the Healthcare sector. Disclosed Capitol has indexed 30 disclosed congressional trades involving TDOC. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of March 2026 — Disclosed Capitol has tracked 30 disclosed congressional trades in Teladoc Health, Inc. (TDOC) — 16:14 buy-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jan 6, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Dec 12, 2025 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Sep 19, 2025 | Tony Wied | R | Sell | $1,001 - $15,000 |
| Feb 19, 2025 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Feb 5, 2025 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Jan 29, 2025 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Jan 17, 2025 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Jan 12, 2025 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Jun 29, 2023 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Jun 26, 2023 | Ro Khanna | D | Buy | $1,001 - $15,000 |
Across the 30 disclosed congressional trades in Teladoc Health, Inc. (TDOC), members of Congress have reported 16 buys and 14 sells. The average 30-day alpha vs. the S&P 500 is -0.01%.
For fiscal year 2025, Teladoc Health, Inc. reported revenue of $2.60B and net income of -$220.4M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $606.9M, net income -$38.9M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.